| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 24.214 | 72.775 | 86.720 | 77.139 | 79.847 | 81.467 |
| Total Income - EUR | - | - | - | 0 | 24.214 | 72.785 | 86.732 | 77.145 | 79.852 | 81.474 |
| Total Expenses - EUR | - | - | - | 5.289 | 21.379 | 18.225 | 22.124 | 30.824 | 22.335 | 33.791 |
| Gross Profit/Loss - EUR | - | - | - | -5.289 | 2.835 | 54.560 | 64.608 | 46.322 | 57.517 | 47.682 |
| Net Profit/Loss - EUR | - | - | - | -5.289 | 2.679 | 53.817 | 63.758 | 45.565 | 56.744 | 45.287 |
| Employees | - | - | - | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Onco-Medint Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 5.404 |
| Current Assets | - | - | - | 19 | 22.076 | 53.892 | 64.936 | 46.722 | 57.572 | 43.774 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 4.477 | 331 | 18.967 | 33.717 | 42.917 | 28.111 |
| Cash | - | - | - | 19 | 17.599 | 22.550 | 45.968 | 13.005 | 14.655 | 15.663 |
| Shareholders Funds | - | - | - | -5.246 | -2.466 | 51.398 | 63.807 | 45.614 | 56.793 | 45.335 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 5.265 | 24.541 | 2.494 | 1.129 | 1.108 | 780 | 3.843 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Onco-Medint Srl